CalciMedica Reports First Quarter 2023 Financial Results and Provides Clinical & Corporate Updates
LA JOLLA, Calif., May 15, 2023 -- CalciMedica Inc. , a clinical-stage biopharmaceutical company focused on developing therapies for life-threatening inflammatory diseases with high unmet need,... | May 15, 2023